22 jun: Obligationer/middag: Stille slut på ugen med lille renteplus
22 jun: Parken: FCK ansætter ny cheftræner (NY2)
22-06-2012 12:17:00

Heineken Sees Olympics Boosting Exposure in Emerging Markets

Relateret indhold
21 apr - 
Fredagens aktier: Pandora, Mærsk og Vestas faldt i afve..
19 apr - 
Heineken overrasker positivt med fremgang i Europa
12 apr - 
Onsdagens aktier: C20 Cap gik på påskeferie med rekord

By Simon Zekaria

LONDON--Dutch brewing giant Heineken NV (HEIA.AE) hopes to reach untapped audiences in emerging markets through its sponsorship of the Olympic Games this summer, as well as driving share gains in the U.K.

Heineken's sponsorship and marketing chief, Hans Erik Tuijt, told Dow Jones Newswires that the Olympics present an opportunity for the company to align itself with a global event.

"In big cities, where big events are, we want to be part of the conversation," he said.

The world's No. 3 brewer by sales is a sponsor for the Olympics for the first time this year, with sole branding for its flagship premium lager.

While the Olympics typically attracts domestic tourists, analysts expect this year's games to draw more foreign visitors than usual, including from India, China and Russia, as well as being broadcast around the world.

Global brewers are increasingly pushing into emerging markets to cash in on rising incomes and a growing desire for Western brands. But debt-stricken Western Europe remains Heineken's core market, generating 35% of its operating profit in the region, compared with 8% for Anheuser-Busch InBev NV (ABI.BT) and about 1% for SABMiller PLC (SAB.LN), according to Sanford Bernstein.

Heineken and rival Carlsberg A/S (CARL-A.KO), which generates 50% of its operating profit in Western Europe, are seen as over-exposed to the region, where a dire economic situation is pressuring consumer spending, according to analysts.

But the brewer is also aiming to rebuild its brand in the U.K., which, alongside Germany, is Europe's main beer-drinking market. In February, Heineken said its fiscal-year U.K. beer volumes slipped 2.8%, even as it made share gains. Beer volumes in Western Europe fell 1.8% in the first quarter.

"We are still re-branding Heineken in the U.K. That takes time," Mr. Tuijt said.

Amsterdam-based Heineken sponsors other blue-riband sporting events including the UEFA Champions League, Europe's highly lucrative club soccer competition, which also has a huge global appeal.

Mr. Tuijt said Heineken only has eyes for club soccer, even if the UEFA European Championships and FIFA World Cup, each running on alternate four-year cycles, also attract huge audiences.

The larger roster of sponsors, as well as the limited frequency and duration of the competitions dilutes impact and makes it difficult to stand out, he noted.

"For the [European Championships], if you ask consumers in the U.K. who is the sponsor and ask someone in Germany or Spain you would get different answers. If you ask people around the world who is the sponsor of the Champions League, 52% of beer drinkers say it is Heineken, which is a massive number."

Write to Simon Zekaria at simon.zekaria@dowjones.com

(END) Dow Jones Newswires

June 22, 2012 06:17 ET (10:17 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

Novo/Nordea: Sanofi-regnskab indikerer lyspunkt på vækstmarkeder

28-04-2017 11:31:07
Kvartalsregnskabet fra Novo Nordisks store franske rival, Sanofi, vidner om, at diabetesforretningen har haft en en stærk udvikling på vækstmarkederne, mens salget er under pres i USA.Og det er en tendens, som Nordea regner med også kan slå igennem i Novos regnskabstal på onsdag. Det fremgår af et notat.Nordea understreger dog, at det langt fra er ligetil at drage paralleller fra Sanofis regnskab...

Novo-rival slår overskuds- og salgsforventninger i første kvartal - NY

28-04-2017 08:06:11
Den franske medicinalvirksomhed Sanofi, der er blandt Novo Nordisks største konkurrenter, er kommet ud af årets første tre måneder med en bedre indtjening end ventet.I første kvartal endte det justerede overskud per aktie (Business EPS, red.) på 1,42 euro, hvilket var højere end de 1,26 euro, som analytikerne ifølge Bloomberg News havde sat næsen op efter.Den samlede omsætning steg til 8,65 mia. e..

Zealand: Lønmodtagernes Dyrtidsfond er ikke længere storaktionær

27-04-2017 15:09:57
Lønmodtagernes Dyrtidsfond (LD) er ikke længere at kategorisere som storaktionær i Zealand Pharma, efter at fonden har solgt ud af sin beholdning og nu ejer mindre end 5 pct. af den samlede aktiekapital.Det fremgår af en meddelelse fra Zealand Pharma torsdag eftermiddag.- Lønmodtagernes Dyrtidsfond har været en af de største aktionærer i Zealand Pharma siden 2000, hvor LD investerede i Zealand som..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Torsdagens aktier: Novo sparkede det danske marked i ny rekord
2
Zealand: Lønmodtagernes Dyrtidsfond er ikke længere storaktionær
3
Zealand Pharma får 8 mio. kr. i royalty-betaling i første kvartal
4
Aktier/tendens: Danske Bank sætter dagsordenen
5
Mærsk sætter pris på kæmpe tysk opkøb - NY

Relaterede aktiekurser

AB Inbev 102,90 -0,1% Fald i aktiekurs
Heineken 82,05 -0,6% Fald i aktiekurs
Anheuser-Busch Inbev SA .. 112,23 0,0% Aktiekurs uændret
Carlsberg A A/S 659,50 -0,2% Fald i aktiekurs

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2017  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
28. april 2017 14:08:40
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: ReleaseCandidateBuild_20170427.1 - EUROWEB1 - 2017-04-28 14:08:40 - 2017-04-28 14:08:40 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x